What is the current valuation of the Biologic Excipient Market as of 2024?

The overall market valuation was 10.27 USD Billion in 2024. Read More

What is the projected market size for the Biologic Excipient Market in 2035?

The projected valuation for the Biologic Excipient Market is 52.13 USD Billion in 2035. Read More

What is the expected CAGR for the Biologic Excipient Market during the forecast period 2025 - 2035?

The expected CAGR for the Biologic Excipient Market during the forecast period 2025 - 2035 is 15.92%. Read More

Which segment is projected to have the highest valuation in the Biologic Excipient Market by 2035?

The Recombinant segment is projected to reach 24.63 USD Billion by 2035. Read More

What are the key functions of biologic excipients in the market?

Key functions include Stabilizers, Emulsifiers, and Preservatives, with Preservatives projected to reach 24.18 USD Billion by 2035. Read More

Which form of biologic excipients is expected to dominate the market by 2035?

The Powder form is expected to dominate, with a projected valuation of 20.65 USD Billion by 2035. Read More

Who are the leading players in the Biologic Excipient Market?

Key players include BASF SE, Evonik Industries AG, and Merck KGaA, among others. Read More

What is the projected valuation for the Human-Derived segment by 2035?

The Human-Derived segment is projected to reach 15.0 USD Billion by 2035. Read More

How does the market for Monoclonal Antibodies compare to other end-use applications by 2035?

The Monoclonal Antibodies segment is projected to reach 18.72 USD Billion by 2035, indicating strong growth. Read More

What is the expected growth trend for the Biologic Excipient Market in the coming years?

The market appears to be on a robust growth trajectory, driven by increasing demand and innovation. Read More

Biologic Excipient Market

ID: MRFR/HC/29395-HCR

128 Pages

Rahul Gotadki

Last Updated: April 24, 2026

Biological Excipient Market Research Report By Source (Animal-Derived, Human-Derived, Recombinant), By Form (Liquid, Powder, Gel), By Function (Stabilizer, Emulsifier, Preservative), By End-Use Application (Vaccines, Protein Therapeutics, Monoclonal Antibodies) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Source (USD Billion)
  1. 4.1.1 Animal-Derived
  2. 4.1.2 Human-Derived
  3. 4.1.3 Recombinant
2. 4.2 Healthcare, BY Form (USD Billion)
  1. 4.2.1 Liquid
  2. 4.2.2 Powder
  3. 4.2.3 Gel
3. 4.3 Healthcare, BY Function (USD Billion)
  1. 4.3.1 Stabilizer
  2. 4.3.2 Emulsifier
  3. 4.3.3 Preservative
4. 4.4 Healthcare, BY End-Use Application (USD Billion)
  1. 4.4.1 Vaccines
  2. 4.4.2 Protein Therapeutics
  3. 4.4.3 Monoclonal Antibodies
5. 4.5 Healthcare, BY Region (USD Billion)
  1. 4.5.1 North America
    1. 4.5.1.1 US
    2. 4.5.1.2 Canada
  2. 4.5.2 Europe
    1. 4.5.2.1 Germany
    2. 4.5.2.2 UK
    3. 4.5.2.3 France
    4. 4.5.2.4 Russia
    5. 4.5.2.5 Italy
    6. 4.5.2.6 Spain
    7. 4.5.2.7 Rest of Europe
  3. 4.5.3 APAC
    1. 4.5.3.1 China
    2. 4.5.3.2 India
    3. 4.5.3.3 Japan
    4. 4.5.3.4 South Korea
    5. 4.5.3.5 Malaysia
    6. 4.5.3.6 Thailand
    7. 4.5.3.7 Indonesia
    8. 4.5.3.8 Rest of APAC
  4. 4.5.4 South America
    1. 4.5.4.1 Brazil
    2. 4.5.4.2 Mexico
    3. 4.5.4.3 Argentina
    4. 4.5.4.4 Rest of South America
  5. 4.5.5 MEA
    1. 4.5.5.1 GCC Countries
    2. 4.5.5.2 South Africa
    3. 4.5.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 BASF SE (DE)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Evonik Industries AG (DE)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Fujifilm Diosynth Biotechnologies (JP)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Merck KGaA (DE)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 SABIC (SA)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Lonza Group AG (CH)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Cargill, Incorporated (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Wacker Chemie AG (DE)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Hyaluronic Acid (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 NORTH AMERICA MARKET ANALYSIS
3. 6.3 US MARKET ANALYSIS BY SOURCE
4. 6.4 US MARKET ANALYSIS BY FORM
5. 6.5 US MARKET ANALYSIS BY FUNCTION
6. 6.6 US MARKET ANALYSIS BY END-USE APPLICATION
7. 6.7 CANADA MARKET ANALYSIS BY SOURCE
8. 6.8 CANADA MARKET ANALYSIS BY FORM
9. 6.9 CANADA MARKET ANALYSIS BY FUNCTION
10. 6.10 CANADA MARKET ANALYSIS BY END-USE APPLICATION
11. 6.11 EUROPE MARKET ANALYSIS
12. 6.12 GERMANY MARKET ANALYSIS BY SOURCE
13. 6.13 GERMANY MARKET ANALYSIS BY FORM
14. 6.14 GERMANY MARKET ANALYSIS BY FUNCTION
15. 6.15 GERMANY MARKET ANALYSIS BY END-USE APPLICATION
16. 6.16 UK MARKET ANALYSIS BY SOURCE
17. 6.17 UK MARKET ANALYSIS BY FORM
18. 6.18 UK MARKET ANALYSIS BY FUNCTION
19. 6.19 UK MARKET ANALYSIS BY END-USE APPLICATION
20. 6.20 FRANCE MARKET ANALYSIS BY SOURCE
21. 6.21 FRANCE MARKET ANALYSIS BY FORM
22. 6.22 FRANCE MARKET ANALYSIS BY FUNCTION
23. 6.23 FRANCE MARKET ANALYSIS BY END-USE APPLICATION
24. 6.24 RUSSIA MARKET ANALYSIS BY SOURCE
25. 6.25 RUSSIA MARKET ANALYSIS BY FORM
26. 6.26 RUSSIA MARKET ANALYSIS BY FUNCTION
27. 6.27 RUSSIA MARKET ANALYSIS BY END-USE APPLICATION
28. 6.28 ITALY MARKET ANALYSIS BY SOURCE
29. 6.29 ITALY MARKET ANALYSIS BY FORM
30. 6.30 ITALY MARKET ANALYSIS BY FUNCTION
31. 6.31 ITALY MARKET ANALYSIS BY END-USE APPLICATION
32. 6.32 SPAIN MARKET ANALYSIS BY SOURCE
33. 6.33 SPAIN MARKET ANALYSIS BY FORM
34. 6.34 SPAIN MARKET ANALYSIS BY FUNCTION
35. 6.35 SPAIN MARKET ANALYSIS BY END-USE APPLICATION
36. 6.36 REST OF EUROPE MARKET ANALYSIS BY SOURCE
37. 6.37 REST OF EUROPE MARKET ANALYSIS BY FORM
38. 6.38 REST OF EUROPE MARKET ANALYSIS BY FUNCTION
39. 6.39 REST OF EUROPE MARKET ANALYSIS BY END-USE APPLICATION
40. 6.40 APAC MARKET ANALYSIS
41. 6.41 CHINA MARKET ANALYSIS BY SOURCE
42. 6.42 CHINA MARKET ANALYSIS BY FORM
43. 6.43 CHINA MARKET ANALYSIS BY FUNCTION
44. 6.44 CHINA MARKET ANALYSIS BY END-USE APPLICATION
45. 6.45 INDIA MARKET ANALYSIS BY SOURCE
46. 6.46 INDIA MARKET ANALYSIS BY FORM
47. 6.47 INDIA MARKET ANALYSIS BY FUNCTION
48. 6.48 INDIA MARKET ANALYSIS BY END-USE APPLICATION
49. 6.49 JAPAN MARKET ANALYSIS BY SOURCE
50. 6.50 JAPAN MARKET ANALYSIS BY FORM
51. 6.51 JAPAN MARKET ANALYSIS BY FUNCTION
52. 6.52 JAPAN MARKET ANALYSIS BY END-USE APPLICATION
53. 6.53 SOUTH KOREA MARKET ANALYSIS BY SOURCE
54. 6.54 SOUTH KOREA MARKET ANALYSIS BY FORM
55. 6.55 SOUTH KOREA MARKET ANALYSIS BY FUNCTION
56. 6.56 SOUTH KOREA MARKET ANALYSIS BY END-USE APPLICATION
57. 6.57 MALAYSIA MARKET ANALYSIS BY SOURCE
58. 6.58 MALAYSIA MARKET ANALYSIS BY FORM
59. 6.59 MALAYSIA MARKET ANALYSIS BY FUNCTION
60. 6.60 MALAYSIA MARKET ANALYSIS BY END-USE APPLICATION
61. 6.61 THAILAND MARKET ANALYSIS BY SOURCE
62. 6.62 THAILAND MARKET ANALYSIS BY FORM
63. 6.63 THAILAND MARKET ANALYSIS BY FUNCTION
64. 6.64 THAILAND MARKET ANALYSIS BY END-USE APPLICATION
65. 6.65 INDONESIA MARKET ANALYSIS BY SOURCE
66. 6.66 INDONESIA MARKET ANALYSIS BY FORM
67. 6.67 INDONESIA MARKET ANALYSIS BY FUNCTION
68. 6.68 INDONESIA MARKET ANALYSIS BY END-USE APPLICATION
69. 6.69 REST OF APAC MARKET ANALYSIS BY SOURCE
70. 6.70 REST OF APAC MARKET ANALYSIS BY FORM
71. 6.71 REST OF APAC MARKET ANALYSIS BY FUNCTION
72. 6.72 REST OF APAC MARKET ANALYSIS BY END-USE APPLICATION
73. 6.73 SOUTH AMERICA MARKET ANALYSIS
74. 6.74 BRAZIL MARKET ANALYSIS BY SOURCE
75. 6.75 BRAZIL MARKET ANALYSIS BY FORM
76. 6.76 BRAZIL MARKET ANALYSIS BY FUNCTION
77. 6.77 BRAZIL MARKET ANALYSIS BY END-USE APPLICATION
78. 6.78 MEXICO MARKET ANALYSIS BY SOURCE
79. 6.79 MEXICO MARKET ANALYSIS BY FORM
80. 6.80 MEXICO MARKET ANALYSIS BY FUNCTION
81. 6.81 MEXICO MARKET ANALYSIS BY END-USE APPLICATION
82. 6.82 ARGENTINA MARKET ANALYSIS BY SOURCE
83. 6.83 ARGENTINA MARKET ANALYSIS BY FORM
84. 6.84 ARGENTINA MARKET ANALYSIS BY FUNCTION
85. 6.85 ARGENTINA MARKET ANALYSIS BY END-USE APPLICATION
86. 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY SOURCE
87. 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY FORM
88. 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY FUNCTION
89. 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY END-USE APPLICATION
90. 6.90 MEA MARKET ANALYSIS
91. 6.91 GCC COUNTRIES MARKET ANALYSIS BY SOURCE
92. 6.92 GCC COUNTRIES MARKET ANALYSIS BY FORM
93. 6.93 GCC COUNTRIES MARKET ANALYSIS BY FUNCTION
94. 6.94 GCC COUNTRIES MARKET ANALYSIS BY END-USE APPLICATION
95. 6.95 SOUTH AFRICA MARKET ANALYSIS BY SOURCE
96. 6.96 SOUTH AFRICA MARKET ANALYSIS BY FORM
97. 6.97 SOUTH AFRICA MARKET ANALYSIS BY FUNCTION
98. 6.98 SOUTH AFRICA MARKET ANALYSIS BY END-USE APPLICATION
99. 6.99 REST OF MEA MARKET ANALYSIS BY SOURCE
100. 6.100 REST OF MEA MARKET ANALYSIS BY FORM
101. 6.101 REST OF MEA MARKET ANALYSIS BY FUNCTION
102. 6.102 REST OF MEA MARKET ANALYSIS BY END-USE APPLICATION
103. 6.103 KEY BUYING CRITERIA OF HEALTHCARE
104. 6.104 RESEARCH PROCESS OF MRFR
105. 6.105 DRO ANALYSIS OF HEALTHCARE
106. 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE
107. 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
108. 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE
109. 6.109 HEALTHCARE, BY SOURCE, 2024 (% SHARE)
110. 6.110 HEALTHCARE, BY SOURCE, 2024 TO 2035 (USD Billion)
111. 6.111 HEALTHCARE, BY FORM, 2024 (% SHARE)
112. 6.112 HEALTHCARE, BY FORM, 2024 TO 2035 (USD Billion)
113. 6.113 HEALTHCARE, BY FUNCTION, 2024 (% SHARE)
114. 6.114 HEALTHCARE, BY FUNCTION, 2024 TO 2035 (USD Billion)
115. 6.115 HEALTHCARE, BY END-USE APPLICATION, 2024 (% SHARE)
116. 6.116 HEALTHCARE, BY END-USE APPLICATION, 2024 TO 2035 (USD Billion)
117. 6.117 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY SOURCE, 2025-2035 (USD Billion)
  2. 7.2.2 BY FORM, 2025-2035 (USD Billion)
  3. 7.2.3 BY FUNCTION, 2025-2035 (USD Billion)
  4. 7.2.4 BY END-USE APPLICATION, 2025-2035 (USD Billion)
2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.3.1 BY SOURCE, 2025-2035 (USD Billion)
  2. 7.3.2 BY FORM, 2025-2035 (USD Billion)
  3. 7.3.3 BY FUNCTION, 2025-2035 (USD Billion)
  4. 7.3.4 BY END-USE APPLICATION, 2025-2035 (USD Billion)
3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  1. 7.4.1 BY SOURCE, 2025-2035 (USD Billion)
  2. 7.4.2 BY FORM, 2025-2035 (USD Billion)
  3. 7.4.3 BY FUNCTION, 2025-2035 (USD Billion)
  4. 7.4.4 BY END-USE APPLICATION, 2025-2035 (USD Billion)
4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.5.1 BY SOURCE, 2025-2035 (USD Billion)
  2. 7.5.2 BY FORM, 2025-2035 (USD Billion)
  3. 7.5.3 BY FUNCTION, 2025-2035 (USD Billion)
  4. 7.5.4 BY END-USE APPLICATION, 2025-2035 (USD Billion)
5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  1. 7.6.1 BY SOURCE, 2025-2035 (USD Billion)
  2. 7.6.2 BY FORM, 2025-2035 (USD Billion)
  3. 7.6.3 BY FUNCTION, 2025-2035 (USD Billion)
  4. 7.6.4 BY END-USE APPLICATION, 2025-2035 (USD Billion)
6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.7.1 BY SOURCE, 2025-2035 (USD Billion)
  2. 7.7.2 BY FORM, 2025-2035 (USD Billion)
  3. 7.7.3 BY FUNCTION, 2025-2035 (USD Billion)
  4. 7.7.4 BY END-USE APPLICATION, 2025-2035 (USD Billion)
7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
  1. 7.8.1 BY SOURCE, 2025-2035 (USD Billion)
  2. 7.8.2 BY FORM, 2025-2035 (USD Billion)
  3. 7.8.3 BY FUNCTION, 2025-2035 (USD Billion)
  4. 7.8.4 BY END-USE APPLICATION, 2025-2035 (USD Billion)
8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  1. 7.9.1 BY SOURCE, 2025-2035 (USD Billion)
  2. 7.9.2 BY FORM, 2025-2035 (USD Billion)
  3. 7.9.3 BY FUNCTION, 2025-2035 (USD Billion)
  4. 7.9.4 BY END-USE APPLICATION, 2025-2035 (USD Billion)
9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  1. 7.10.1 BY SOURCE, 2025-2035 (USD Billion)
  2. 7.10.2 BY FORM, 2025-2035 (USD Billion)
  3. 7.10.3 BY FUNCTION, 2025-2035 (USD Billion)
  4. 7.10.4 BY END-USE APPLICATION, 2025-2035 (USD Billion)
10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  1. 7.11.1 BY SOURCE, 2025-2035 (USD Billion)
  2. 7.11.2 BY FORM, 2025-2035 (USD Billion)
  3. 7.11.3 BY FUNCTION, 2025-2035 (USD Billion)
  4. 7.11.4 BY END-USE APPLICATION, 2025-2035 (USD Billion)
11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.12.1 BY SOURCE, 2025-2035 (USD Billion)
  2. 7.12.2 BY FORM, 2025-2035 (USD Billion)
  3. 7.12.3 BY FUNCTION, 2025-2035 (USD Billion)
  4. 7.12.4 BY END-USE APPLICATION, 2025-2035 (USD Billion)
12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.13.1 BY SOURCE, 2025-2035 (USD Billion)
  2. 7.13.2 BY FORM, 2025-2035 (USD Billion)
  3. 7.13.3 BY FUNCTION, 2025-2035 (USD Billion)
  4. 7.13.4 BY END-USE APPLICATION, 2025-2035 (USD Billion)
13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
  1. 7.14.1 BY SOURCE, 2025-2035 (USD Billion)
  2. 7.14.2 BY FORM, 2025-2035 (USD Billion)
  3. 7.14.3 BY FUNCTION, 2025-2035 (USD Billion)
  4. 7.14.4 BY END-USE APPLICATION, 2025-2035 (USD Billion)
14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
  1. 7.15.1 BY SOURCE, 2025-2035 (USD Billion)
  2. 7.15.2 BY FORM, 2025-2035 (USD Billion)
  3. 7.15.3 BY FUNCTION, 2025-2035 (USD Billion)
  4. 7.15.4 BY END-USE APPLICATION, 2025-2035 (USD Billion)
15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  1. 7.16.1 BY SOURCE, 2025-2035 (USD Billion)
  2. 7.16.2 BY FORM, 2025-2035 (USD Billion)
  3. 7.16.3 BY FUNCTION, 2025-2035 (USD Billion)
  4. 7.16.4 BY END-USE APPLICATION, 2025-2035 (USD Billion)
16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.17.1 BY SOURCE, 2025-2035 (USD Billion)
  2. 7.17.2 BY FORM, 2025-2035 (USD Billion)
  3. 7.17.3 BY FUNCTION, 2025-2035 (USD Billion)
  4. 7.17.4 BY END-USE APPLICATION, 2025-2035 (USD Billion)
17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  1. 7.18.1 BY SOURCE, 2025-2035 (USD Billion)
  2. 7.18.2 BY FORM, 2025-2035 (USD Billion)
  3. 7.18.3 BY FUNCTION, 2025-2035 (USD Billion)
  4. 7.18.4 BY END-USE APPLICATION, 2025-2035 (USD Billion)
18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  1. 7.19.1 BY SOURCE, 2025-2035 (USD Billion)
  2. 7.19.2 BY FORM, 2025-2035 (USD Billion)
  3. 7.19.3 BY FUNCTION, 2025-2035 (USD Billion)
  4. 7.19.4 BY END-USE APPLICATION, 2025-2035 (USD Billion)
19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  1. 7.20.1 BY SOURCE, 2025-2035 (USD Billion)
  2. 7.20.2 BY FORM, 2025-2035 (USD Billion)
  3. 7.20.3 BY FUNCTION, 2025-2035 (USD Billion)
  4. 7.20.4 BY END-USE APPLICATION, 2025-2035 (USD Billion)
20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.21.1 BY SOURCE, 2025-2035 (USD Billion)
  2. 7.21.2 BY FORM, 2025-2035 (USD Billion)
  3. 7.21.3 BY FUNCTION, 2025-2035 (USD Billion)
  4. 7.21.4 BY END-USE APPLICATION, 2025-2035 (USD Billion)
21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.22.1 BY SOURCE, 2025-2035 (USD Billion)
  2. 7.22.2 BY FORM, 2025-2035 (USD Billion)
  3. 7.22.3 BY FUNCTION, 2025-2035 (USD Billion)
  4. 7.22.4 BY END-USE APPLICATION, 2025-2035 (USD Billion)
22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  1. 7.23.1 BY SOURCE, 2025-2035 (USD Billion)
  2. 7.23.2 BY FORM, 2025-2035 (USD Billion)
  3. 7.23.3 BY FUNCTION, 2025-2035 (USD Billion)
  4. 7.23.4 BY END-USE APPLICATION, 2025-2035 (USD Billion)
23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  1. 7.24.1 BY SOURCE, 2025-2035 (USD Billion)
  2. 7.24.2 BY FORM, 2025-2035 (USD Billion)
  3. 7.24.3 BY FUNCTION, 2025-2035 (USD Billion)
  4. 7.24.4 BY END-USE APPLICATION, 2025-2035 (USD Billion)
24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  1. 7.25.1 BY SOURCE, 2025-2035 (USD Billion)
  2. 7.25.2 BY FORM, 2025-2035 (USD Billion)
  3. 7.25.3 BY FUNCTION, 2025-2035 (USD Billion)
  4. 7.25.4 BY END-USE APPLICATION, 2025-2035 (USD Billion)
25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.26.1 BY SOURCE, 2025-2035 (USD Billion)
  2. 7.26.2 BY FORM, 2025-2035 (USD Billion)
  3. 7.26.3 BY FUNCTION, 2025-2035 (USD Billion)
  4. 7.26.4 BY END-USE APPLICATION, 2025-2035 (USD Billion)
26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.27.1 BY SOURCE, 2025-2035 (USD Billion)
  2. 7.27.2 BY FORM, 2025-2035 (USD Billion)
  3. 7.27.3 BY FUNCTION, 2025-2035 (USD Billion)
  4. 7.27.4 BY END-USE APPLICATION, 2025-2035 (USD Billion)
27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  1. 7.28.1 BY SOURCE, 2025-2035 (USD Billion)
  2. 7.28.2 BY FORM, 2025-2035 (USD Billion)
  3. 7.28.3 BY FUNCTION, 2025-2035 (USD Billion)
  4. 7.28.4 BY END-USE APPLICATION, 2025-2035 (USD Billion)
28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  1. 7.29.1 BY SOURCE, 2025-2035 (USD Billion)
  2. 7.29.2 BY FORM, 2025-2035 (USD Billion)
  3. 7.29.3 BY FUNCTION, 2025-2035 (USD Billion)
  4. 7.29.4 BY END-USE APPLICATION, 2025-2035 (USD Billion)
29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.30.1 BY SOURCE, 2025-2035 (USD Billion)
  2. 7.30.2 BY FORM, 2025-2035 (USD Billion)
  3. 7.30.3 BY FUNCTION, 2025-2035 (USD Billion)
  4. 7.30.4 BY END-USE APPLICATION, 2025-2035 (USD Billion)
30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
1. 7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Biologic Excipient Market Segmentation

Biologic Excipient Market By Source (USD Billion, 2025-2035)

Animal-Derived
Human-Derived
Recombinant

Biologic Excipient Market By Form (USD Billion, 2025-2035)

Liquid
Powder
Gel

Biologic Excipient Market By Function (USD Billion, 2025-2035)

Stabilizer
Emulsifier
Preservative

Biologic Excipient Market By End-Use Application (USD Billion, 2025-2035)

Vaccines
Protein Therapeutics
Monoclonal Antibodies

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”